{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:23:54Z","timestamp":1790821434878,"version":"4.1.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ecl.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T18:48:11Z","timestamp":1525978091000},"page":"275-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Genetics of Cushing\u2019s Syndrome"],"prefix":"10.1016","volume":"47","author":[{"given":"Laura C.","family":"Hern\u00e1ndez-Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9996","key":"10.1016\/j.ecl.2018.02.007_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ecl.2018.02.007_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1055\/s-0034-1389993","article-title":"From beta-catenin to ARM-repeat proteins in adrenocortical disorders","volume":"46","author":"Berthon","year":"2014","journal-title":"Horm Metab Res"},{"issue":"10","key":"10.1016\/j.ecl.2018.02.007_bib3","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1210\/jc.2008-0631","article-title":"Wnt\/beta-catenin and 3\u2032,5\u2032-cyclic adenosine 5\u2032-monophosphate\/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors","volume":"93","author":"Gaujoux","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2265.2007.03033.x","article-title":"Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas","volume":"68","author":"Tadjine","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib5","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2010-1885","article-title":"Wnt\/beta-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors","volume":"96","author":"Bonnet","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.ecl.2018.02.007_bib6","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.007_bib7","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.ecl.2018.02.007_bib8","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.ecl.2018.02.007_bib9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6186","key":"10.1016\/j.ecl.2018.02.007_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1126\/science.1249480","article-title":"Activating hotspot L205R mutation in PRKACA and adrenal Cushing\u2019s syndrome","volume":"344","author":"Cao","year":"2014","journal-title":"Science"},{"issue":"6186","key":"10.1016\/j.ecl.2018.02.007_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1126\/science.1252328","article-title":"Recurrent somatic mutations underlie corticotropin-independent Cushing\u2019s syndrome","volume":"344","author":"Sato","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2956","article-title":"Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors","volume":"46","author":"Goh","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","article-title":"Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations","volume":"172","author":"Lodish","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.007_bib14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A\u00a0genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.007_bib15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMc0706182","article-title":"Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia","volume":"358","author":"Horvath","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ecl.2018.02.007_bib16","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ejhg.2008.85","article-title":"A\u00a0cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex","volume":"16","author":"Horvath","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"22","key":"10.1016\/j.ecl.2018.02.007_bib17","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome","volume":"369","author":"Assie","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib18","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib19","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1530\/EJE-15-0205","article-title":"The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2018.02.007_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.06.027","article-title":"The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH)","volume":"460","author":"Cavalcante","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"18","key":"10.1016\/j.ecl.2018.02.007_bib22","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/hmg\/ddx235","article-title":"Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function","volume":"26","author":"Berthon","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib23","doi-asserted-by":"crossref","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","article-title":"ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.007_bib24","doi-asserted-by":"crossref","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","article-title":"ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib25","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1530\/ERC-12-0118","article-title":"Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and\/or Krebs cycle defects?","volume":"19","author":"Xekouki","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib26","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JOE-14-0568","article-title":"Genetics of primary macronodular adrenal hyperplasia","volume":"224","author":"Fragoso","year":"2015","journal-title":"J\u00a0Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib27","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib28","first-page":"430","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"22","key":"10.1016\/j.ecl.2018.02.007_bib29","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.ecl.2018.02.007_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92184","article-title":"Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing\u2019s syndrome","volume":"2","author":"Lecoq","year":"2017","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.ecl.2018.02.007_bib31","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1210\/me.2002-0099","article-title":"Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity","volume":"16","author":"Swords","year":"2002","journal-title":"Mol Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2003.10.052","article-title":"Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missense mutations in the MC2R gene","volume":"213","author":"Swords","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2018.02.007_bib33","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1750-1172-7-S1-S4","article-title":"McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia","volume":"7","author":"Collins","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"6236","key":"10.1016\/j.ecl.2018.02.007_bib34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib35","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2009-2321","article-title":"Cushing syndrome in the McCune-Albright syndrome","volume":"95","author":"Brown","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib36","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/PAS.0b013e31821ec4ce","article-title":"Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome","volume":"35","author":"Carney","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2362.1995.tb01537.x","article-title":"G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas","volume":"25","author":"Williamson","year":"1995","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/mp.55.1.58","article-title":"An R201H activating mutation of the GNAS1 (Gsalpha) gene in a corticotroph pituitary adenoma","volume":"55","author":"Riminucci","year":"2002","journal-title":"Mol Pathol"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2018.02.007_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib41","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.007_bib42","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"5311","key":"10.1016\/j.ecl.2018.02.007_bib43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2018.02.007_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years","volume":"209","author":"Concolino","year":"2016","journal-title":"Cancer Genet"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2265.2011.04220.x","article-title":"Cushing\u2019s syndrome in multiple endocrine neoplasia type 1","volume":"76","author":"Simonds","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verges","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2018.02.007_bib48","doi-asserted-by":"crossref","first-page":"E1905","DOI":"10.1210\/jc.2011-1127","article-title":"Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma","volume":"96","author":"Farrell","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib49","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 Study Group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib50","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019etude des Tumeurs Endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib52","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib53","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1530\/EJE-15-0209","article-title":"Carney complex: an update","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI118467","article-title":"Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2","volume":"97","author":"Stratakis","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.ecl.2018.02.007_bib56","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMc1309730","article-title":"PRKACB and carney complex","volume":"370","author":"Forlino","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib57","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.1210\/jc.2013-3159","article-title":"Deletions of the PRKAR1A Locus at 17q24.2-q24.3 in carney complex: genotype-phenotype correlations and implications for genetic testing","volume":"99","author":"Salpea","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib58","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/humu.21178","article-title":"Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update","volume":"31","author":"Horvath","year":"2010","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib59","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2265.2002.01643.x","article-title":"Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours","volume":"57","author":"Kaltsas","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.ecl.2018.02.007_bib60","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1136\/jmg.39.12.e78","article-title":"PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex","volume":"39","author":"Sandrini","year":"2002","journal-title":"J\u00a0Med Genet"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib61","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1399-0004.2010.01406.x","article-title":"The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes","volume":"78","author":"Stratakis","year":"2010","journal-title":"Clin Genet"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib62","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1158\/0008-5472.CAN-08-0064","article-title":"Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors","volume":"68","author":"Meoli","year":"2008","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib63","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.007_bib64","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-131-8-199910190-00006","article-title":"Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease","volume":"131","author":"Stratakis","year":"1999","journal-title":"Ann Intern Med"},{"issue":"6\u20137","key":"10.1016\/j.ecl.2018.02.007_bib65","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-2007-978914","article-title":"Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome","volume":"30","author":"Stratakis","year":"1998","journal-title":"Horm Metab Res"},{"issue":"15","key":"10.1016\/j.ecl.2018.02.007_bib66","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMcpc010057","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-2002. A 27-year-old woman with two intracardiac masses and a history of endocrinopathy","volume":"346","author":"Basson","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.007_bib67","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/js.2017-00231","article-title":"Corticotropinoma as a Component of Carney Complex","volume":"1","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib68","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-17-0227","article-title":"PRKAR1A mutation causing pituitary-dependent Cushing disease in a patient with Carney complex","volume":"177","author":"Kiefer","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ecl.2018.02.007_bib69","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1210\/jc.2015-1453","article-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing\u2019s disease","volume":"100","author":"P\u00e9rez-Rivas","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib71","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.007_bib72","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1210\/jc.2017-00161","article-title":"Somatic USP8 gene mutations are a common cause of pediatric Cushing disease","volume":"102","author":"Faucz","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2018.02.007_bib73","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1091\/mbc.e05-06-0560","article-title":"Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes","volume":"16","author":"Mizuno","year":"2005","journal-title":"Mol Biol Cell"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-15-0689","article-title":"The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing\u2019s disease","volume":"174","author":"Hayashi","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-17-0634","article-title":"Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson\u2019s tumor","volume":"178","author":"P\u00e9rez-Rivas","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib76","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1074\/jbc.273.6.3129","article-title":"Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells","volume":"273","author":"Kemppainen","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib77","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1210\/endo.142.6.8209","article-title":"Dexras1\/AGS-1, a steroid hormone-induced guanosine triphosphate-binding protein, inhibits 3\u2019,5\u2019-cyclic adenosine monophosphate-stimulated secretion in AtT-20 corticotroph cells","volume":"142","author":"Graham","year":"2001","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib78","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/12867","article-title":"Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling","volume":"17","author":"Cismowski","year":"1999","journal-title":"Nat Biotechnol"},{"issue":"13","key":"10.1016\/j.ecl.2018.02.007_bib79","doi-asserted-by":"crossref","first-page":"10876","DOI":"10.1074\/jbc.M110397200","article-title":"Dexras1\/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1\/2 MAP kinases","volume":"277","author":"Graham","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib80","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2004.08.021","article-title":"Dexras1 potentiates photic and suppresses nonphotic responses of the circadian clock","volume":"43","author":"Cheng","year":"2004","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib81","doi-asserted-by":"crossref","first-page":"a001602","DOI":"10.1101\/mcs.a001602","article-title":"Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma","volume":"3","author":"Uzilov","year":"2017","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12022-007-9006-y","article-title":"P53 gene mutations in pituitary carcinomas","volume":"18","author":"Tanizaki","year":"2007","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib83","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2265.2008.03404.x","article-title":"P53 gene mutation in an atypical corticotroph adenoma with Cushing\u2019s disease","volume":"70","author":"Kawashima","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib84","first-page":"1513","article-title":"P53 protein accumulates in Cushing\u2019s adenomas and invasive non-functional adenomas","volume":"79","author":"Buckley","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib85","first-page":"296","article-title":"Cushing\u2019s disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation","volume":"108","author":"Karl","year":"1996","journal-title":"Proc Assoc Am Physicians"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib86","first-page":"124","article-title":"Nelson\u2019s syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene","volume":"81","author":"Karl","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib87","first-page":"1088","article-title":"Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors","volume":"82","author":"Dahia","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib88","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1365-2265.2002.01639.x","article-title":"Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours","volume":"57","author":"Antonini","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.007_bib89","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update","volume":"98","author":"Wells","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2018.02.007_bib90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mce.2005.10.028","article-title":"Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside","volume":"247","author":"Machens","year":"2006","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib91","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MAJ.0b013e3181e73fba","article-title":"Coincidence of multiple endocrine neoplasia type 2A with acromegaly","volume":"340","author":"Saito","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ecl.2018.02.007_bib92","first-page":"732452","article-title":"Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma","volume":"2011","author":"Heinlen","year":"2011","journal-title":"ISRN Oncol"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib93","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/cen.12072","article-title":"Confusing genes: a patient with MEN2A and Cushing\u2019s disease","volume":"78","author":"Naziat","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2018.02.007_bib94","first-page":"1","article-title":"Cushing disease in a patient with multiple endocrine neoplasia type 2B","volume":"4","author":"Kasturi","year":"2017","journal-title":"J\u00a0Clin Transl Endocrinol Case Rep"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib95","doi-asserted-by":"crossref","first-page":"T105","DOI":"10.1530\/ERC-15-0241","article-title":"15 years of paraganglioma: the association of pituitary adenomas and phaeochromocytomas or paragangliomas","volume":"22","author":"O'Toole","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"42","key":"10.1016\/j.ecl.2018.02.007_bib96","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.007_bib97","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib98","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib99","first-page":"781","article-title":"Multiple endocrine neoplasia syndromes associated with mutation of p27","volume":"36","author":"Lee","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"11","key":"10.1016\/j.ecl.2018.02.007_bib100","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1002\/humu.21354","article-title":"A\u00a0novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib101","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2265.2011.04269.x","article-title":"Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain","volume":"76","author":"Belar","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib102","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-11-0929","article-title":"Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia (MEN)-like phenotype","volume":"166","author":"Malanga","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib103","doi-asserted-by":"crossref","first-page":"e1003350","DOI":"10.1371\/journal.pgen.1003350","article-title":"A\u00a0novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype","volume":"9","author":"Occhi","year":"2013","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-14-0116","article-title":"Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4)","volume":"4","author":"Pardi","year":"2015","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-015-0540-y","article-title":"Early onset acromegaly associated with a novel deletion in CDKN1B 5\u2019UTR region","volume":"49","author":"Sambugaro","year":"2015","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib106","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0092-8674(00)81239-8","article-title":"A\u00a0syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice","volume":"85","author":"Fero","year":"1996","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib107","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(00)81238-6","article-title":"Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)","volume":"85","author":"Kiyokawa","year":"1996","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib108","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0092-8674(00)81237-4","article-title":"Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors","volume":"85","author":"Nakayama","year":"1996","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib109","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1365-2265.2008.03368.x","article-title":"SDHC mutation in an elderly patient without familial antecedents","volume":"69","author":"Lopez-Jimenez","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib110","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1210\/jc.2011-1179","article-title":"Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?","volume":"97","author":"Xekouki","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib111","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.endonu.2012.02.009","article-title":"Coexistence of a pituitary macroadenoma and multicentric paraganglioma: a strange coincidence","volume":"60","author":"Varsavsky","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.ecl.2018.02.007_bib112","unstructured":"Dematti S, Branz G, Casagranda G, et\u00a0al. Pituitary tumors in SDH mutation carriers. 12th ENSAT Meeting. 2013. p. 29."},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib113","doi-asserted-by":"crossref","first-page":"E1103","DOI":"10.1210\/jc.2013-1400","article-title":"Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma\/paraganglioma","volume":"98","author":"Dwight","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2018.02.007_bib114","doi-asserted-by":"crossref","first-page":"E1386","DOI":"10.1210\/jc.2015-2689","article-title":"Succinate dehydrogenase (SDH)-deficient pancreatic neuroendocrine tumor expands the SDH-related tumor spectrum","volume":"100","author":"Niemeijer","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib115","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1210\/jc.2014-4297","article-title":"Pituitary adenoma with paraganglioma\/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice","volume":"100","author":"Xekouki","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib116","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s11102-015-0672-3","article-title":"Cushing\u2019s disease and co-existing phaeochromocytoma","volume":"19","author":"Johnston","year":"2016","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib117","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40792-016-0214-x","article-title":"Concomitant existence of pheochromocytoma in a patient with multiple endocrine neoplasia type 1","volume":"2","author":"Okada","year":"2016","journal-title":"Surg Case Rep"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib118","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.endonu.2016.07.007","article-title":"Pituitary adenoma associated with pheochromocytoma\/paraganglioma: a new form of multiple endocrine neoplasia","volume":"63","author":"Guerrero Perez","year":"2016","journal-title":"Endocrinol Nutr"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib119","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-17-0074","article-title":"The phenotype of SDHB germline mutation carriers: a nationwide study","volume":"177","author":"Niemeijer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2018.02.007_bib120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1353.011","article-title":"Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes","volume":"1073","author":"Benn","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib121","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/pbc.22338","article-title":"Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma","volume":"54","author":"Majumdar","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-13-0623","article-title":"Non-pheochromocytoma (PCC)\/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis","volume":"170","author":"Papathomas","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib123","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort","volume":"100","author":"Denes","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2018.02.007_bib124","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/js.2017-00135","article-title":"Case report of a prolactinoma in a patient with a novel MAX mutation and bilateral pheochromocytomas","volume":"1","author":"Roszko","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ecl.2018.02.007_bib125","first-page":"OR41","article-title":"Familial pituitary adenoma and paraganglioma syndrome - a novel type of multiple endocrine neoplasia","volume":"33","author":"Denes","year":"2012","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib126","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005792-196809000-00001","article-title":"Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing\u2019s disease: multiple endocrine neoplasia, type 2","volume":"47","author":"Steiner","year":"1968","journal-title":"Medicine (Baltimore)"},{"issue":"5777","key":"10.1016\/j.ecl.2018.02.007_bib127","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib128","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1210\/jc.2005-2671","article-title":"Clinical characterization of familial isolated pituitary adenomas","volume":"91","author":"Daly","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib129","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers","volume":"100","author":"Hernandez-Ramirez","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2018.02.007_bib130","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1210\/jc.2009-2556","article-title":"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study","volume":"95","author":"Daly","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib131","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients","volume":"22","author":"Rostomyan","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.007_bib132","doi-asserted-by":"crossref","first-page":"E1411","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway","volume":"97","author":"Chahal","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2018.02.007_bib133","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/onc.2014.50","article-title":"AIP inactivation leads to pituitary tumorigenesis through defective Galphai-cAMP signaling","volume":"34","author":"Tuominen","year":"2015","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.ecl.2018.02.007_bib134","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1073\/pnas.0700004104","article-title":"Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations","volume":"104","author":"Georgitsi","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib135","doi-asserted-by":"crossref","first-page":"E663","DOI":"10.1210\/jc.2011-2291","article-title":"Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients","volume":"97","author":"Cazabat","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib136","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-0043-104700","article-title":"Role of phosphodiesterases on the function of aryl hydrocarbon receptor-interacting protein (AIP) in the pituitary gland and on the evaluation of AIP gene variants","volume":"49","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib137","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-07-0348","article-title":"The clinical, pathological, and genetic features of familial isolated pituitary adenomas","volume":"157","author":"Beckers","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib138","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ecl.2018.02.007_bib139","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1530\/ERC-16-0091","article-title":"Screening for GPR101 defects in pediatric pituitary corticotropinomas","volume":"23","author":"Trivellin","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2015-3324","article-title":"The Cables1 gene in glucocorticoid regulation of pituitary corticotrope growth and Cushing disease","volume":"101","author":"Roussel-Gervais","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2018.02.007_bib141","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/mol.116.107730","article-title":"The emerging role of cables1 in cancer and other diseases","volume":"92","author":"Huang","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib142","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1158\/0008-5472.CAN-14-0036","article-title":"Cables1 complex couples survival signaling to the cell death machinery","volume":"75","author":"Shi","year":"2015","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.007_bib143","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/ERC-17-0131","article-title":"Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing\u2019s disease","volume":"24","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"10.1016\/j.ecl.2018.02.007_bib144","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"20","key":"10.1016\/j.ecl.2018.02.007_bib145","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1073\/pnas.1018091108","article-title":"Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib146","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jmg.2010.083790","article-title":"DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome","volume":"48","author":"Slade","year":"2011","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ecl.2018.02.007_bib147","series-title":"GeneReviews","article-title":"DICER1-Related Disorders","author":"Doros","year":"1993"},{"issue":"10","key":"10.1016\/j.ecl.2018.02.007_bib148","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrc3802","article-title":"DICER1: mutations, microRNAs and mechanisms","volume":"14","author":"Foulkes","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2018.02.007_bib149","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.ecl.2018.02.007_bib150","doi-asserted-by":"crossref","first-page":"E1487","DOI":"10.1210\/jc.2014-1016","article-title":"Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing\u2019s disease","volume":"99","author":"Sahakitrungruang","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib151","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-008-0388-9","article-title":"Pituitary blastoma","volume":"116","author":"Scheithauer","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib152","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/path.4827","article-title":"New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex","volume":"241","author":"Lam","year":"2017","journal-title":"J\u00a0Pathol"},{"issue":"6","key":"10.1016\/j.ecl.2018.02.007_bib153","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2265.2005.02374.x","article-title":"Simultaneous Cushing\u2019s disease and tuberous sclerosis; a potential role for TSC in pituitary ontogeny","volume":"63","author":"Tigas","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ecl.2018.02.007_bib154","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.2007.02941.x","article-title":"Cushing\u2019s syndrome due to a pituitary corticotropinoma in a child with tuberous sclerosis: an association or a coincidence?","volume":"67","author":"Nandagopal","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ecl.2018.02.007_bib155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.mce.2006.12.017","article-title":"DAX1: increasing complexity in the roles of this novel nuclear receptor","volume":"265-266","author":"McCabe","year":"2007","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2018.02.007_bib156","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/eje.1.01958","article-title":"Corticotroph adenoma of the pituitary in a patient with X-linked adrenal hypoplasia congenita due to a novel mutation of the DAX-1 gene","volume":"153","author":"De Menis","year":"2005","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985291830015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985291830015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:42:22Z","timestamp":1760175742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985291830015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":156,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S088985291830015X"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2018.02.007","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of Cushing\u2019s Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}